Advertisement
Business

Abraxis to Buy Pfizer Facility in Puerto Rico

By Lisa Girion
Share

Los Angeles biopharmaceutical maker Abraxis BioScience Inc. announced an agreement to buy a Pfizer Inc. manufacturing facility in Barceloneta, Puerto Rico.

The plant will expand Abraxis’ capacity to produce drugs such as Abraxane, which was approved last year for the treatment of advanced breast cancer and is the first anti-cancer agent on the market engineered through nanotechnology.

Financial details were not disclosed.

Under the deal, Abraxis would lease a portion of the site back to the seller to continue the manufacturing of Pfizer’s celecoxib, the active ingredient of Celebrex.

Advertisement

Lisa Girion

More to Read

Business
Lisa Girion

As an investigative reporter at the Los Angeles Times, Lisa Girion produced many high-impact stories, including an investigation into alleged human rights abuses in Myanmar, which was anthologized in “Global Muckraking” (The New Press, 2014). Her investigation into the health insurance practice of dropping sick patients, known as rescission, was cited in the Affordable Care Act. She earned a bachelor’s degree at Northwestern University’s Medill School of Journalism. She left The Times in 2015.

More From the Los Angeles Times

Advertisement